CHI3L1 and neoplasm: The authors of this study observed a 40% decrease in (cell line U87) tumor growth in 5 scid/beige mice treated with an anti-YKL-40 monclonal antibody (mAY) compared with 5 control scid/beige mice whereas we observed a 400% increase in tumor volume in 20 scid mice.